유럽 ​​자동 세포 배양 시장 – 2029년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​자동 세포 배양 시장 – 2029년까지의 산업 동향 및 예측

  • Healthcare
  • Published Report
  • Sep 2022
  • Europe
  • 350 Pages
  • 테이블 수: 184
  • 그림 수: 35

>유럽 ​​자동화 세포 배양 시장, 제품별(소모품, 기기), 유형별(무한 세포주 배양, 유한 세포주 배양), 응용 분야별(약물 개발, 줄기 세포 연구, 재생 의학 , 암 연구, 백신 , 기타), 최종 사용자별(생명공학 회사, 연구 기관, 학술 연구 기관, 기타) 산업 동향 및 2029년까지의 예측.

유럽 ​​자동 세포 배양 시장

유럽 ​​자동 세포 배양 시장 분석 및 통찰력

자동화된 세포 배양 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.

유럽 ​​자동 세포 배양 시장

유럽 ​​자동 세포 배양 시장

유럽 ​​자동화 세포 배양 시장은 2022년에서 2029년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년에서 2029년의 예측 기간 동안 8.2%의 CAGR로 성장하고 있으며 2029년까지 5,807.17백만 유로에 도달할 것으로 예상한다고 분석합니다. 백신 생산에서 세포 배양 기술에 대한 수요 증가 다양한 응용 분야에서 세포 배양 기술의 광범위한 수용이 예측 기간 동안 시장 수요를 촉진한 주요 원동력입니다 .

보고서 메트릭

세부

예측 기간

2022년부터 2029년까지

기준 연도

2021

역사적 연도

2020 (2019-2014까지 사용자 정의 가능)

양적 단위

매출(백만 유로), 볼륨(단위), 가격(유로)

다루는 세그먼트

제품별(소모품, 기구), 유형별(무한 세포주 배양, 유한 세포주 배양), 응용 분야별(약물 개발, 줄기세포 연구, 재생 의학 , 암 연구, 백신 , 기타), 최종 사용자별(바이오텍 기업, 연구 기관, 학술 연구 기관, 기타)

적용 국가

독일, 영국, 프랑스, ​​러시아, 이탈리아, 터키, 네덜란드, 스위스, 스페인, 벨기에 및 기타 유럽 국가

시장 참여자 포함

Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG 및 기타

유럽 ​​자동 세포 배양 시장 정의

Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.

Europe Automated Cell Cultures Market Dynamics

This section deals with understanding the market drivers, opportunity, restraint, and challenge. All of this is discussed in detail below:

  • Drivers

Increasing Demand for Cell Culture Technology in Vaccine Production

Cell culture is an essential tool for molecular and cellular biology research. Today, most biotechnology products primarily rely on mass culturing cell lines. Cell cultures have applications in diverse areas and serve as a model system for numerous research efforts.

An increase in funding from the government for cell-based research is significantly triggering the market's growth. In addition, cell culture techniques are widely being used as an alternative to current egg-based strategies for developing cell-based vaccines. Cell culture has potential applications in developing viral vaccines with increased communicable diseases and pandemic risk. Thus, cell culture technology is being extensively used in developing U.S. licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio.

Technological Advancements in Cell Culture Technology Systems

As the demand for advanced cell culture technologies in vaccine production, cancer research, and virology, among others, is increasing, certain technological developments are taking place in automated cell culture.

Thus, market players operating in the market adopt various technological developments in cell culture equipment to boost their business in various dimensions and lead to market growth. This factor could drive the Europe automated cell cultures market growth.

  • Restraint

High Cost of Automated Cell Culture Systems

The cost of the product is the major setback for the market as it is expected to decrease the demand due to high cost. In the case of automated cell culture systems, the price is also high, and below the given instance will showcase the product's price.

The instruments and consumables-related products such as cell counters, reagents, buffers, and others have high prices, which shows that the cost of automated cell cultures is the primary factor expected to restrain the Europe automated cell cultures market in the forecasted period.

  • Opportunity

New Product Launches and Technology Developments

Pharmaceutical and biotechnology-driven companies are working towards developing and launching new products and technologies for automated cell culture advancement and making the treatment and diagnosis methods more reachable. This has also increased the demand for an automated cell culture market for 3D cell cultures. The development of new bioreactors, platforms, software’s has led to an advancement in the automated cell culture market and its growth.

The new products and technologies launched and worked upon create good opportunities for the Europe automated cell cultures market. The new platforms with advanced technologies act as a footstep closer to the advancement of the market.

  • Challenge

Development and Maintenance of Expertise

Recruitment and retention of trained and qualified staff, staff development, capital budgets for equipment purchase, operating budget management, facility infrastructure, and change management all require proper attention for the growth and success of any market. Failure to meet needs in any of these areas can lead to a serious weakness that, if uncorrected, may compromise the credibility of a laboratory and create a situation that will be difficult to correct in the short term.

Testing and maintaining the level of expertise in testing laboratories is a tough task, and it needs high experience, which sometimes is not accessible, which causes the development process for a particular company to hinder. Thus it is anticipated to challenge the Europe automated cell cultures market growth in the forecasted period.

Recent Developments

  • In July 2021, the life science group Sartorius, Sartorius Stadium Biotech subgroup, acquired a majority stake in the reagent manufacturer CellGenix GmbH.
  • In December 2O2O, Eppendorf presented the new modular bioreactor control system SciVario twin to its bioprocess customers in 2020. Designed to provide more flexibility in the laboratory, it allows users to control two glass bioreactors in the volume range of 0.2 to 40 liters individually or in parallel from a computer or tablet using Eppendorf’s software VisioNize – without the need to change the configuration of the hardware.

Europe Automated Cell Cultures Market Scope

Europe automated cell cultures market is segmented into Product, Type, Application, and End User. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Europe Automated Cell Cultures Market, By Product

  • Consumables
  • Instruments

제품을 기준으로 유럽 자동 세포 배양 시장은 소모품과 장비로 구분됩니다.

유럽 ​​자동 세포 배양 시장, 유형별

  • 무한 세포주 배양
  • 유한 세포주 배양

유형을 기준으로 유럽 자동 세포 배양 시장은 무한 세포주 배양과 유한 세포주 배양으로 구분됩니다.

유럽 ​​자동화 세포 배양 시장, 응용 분야별

  • 약물 개발
  • 줄기세포 연구
  • 재생의학
  • 암 연구
  • 백신
  • 다른

유럽 ​​자동 세포 배양 시장은 응용 분야를 기준으로 약물 개발, 줄기세포 연구, 재생 의학, 암 연구, 백신 및 기타로 구분됩니다.

유럽 ​​자동 세포 배양 시장, 최종 사용자별

  • 바이오텍 회사
  • 연구 기관
  • 학술 연구 기관
  • 다른

자동화된 세포 배양 시장

유럽 ​​자동 세포 배양 시장은 최종 사용자를 기준으로 생명공학 기업, 연구 기관, 학술 연구 기관 및 기타로 구분됩니다.

유럽 ​​자동화 세포 배양 시장 지역 분석/통찰력

유럽 ​​자동 세포 배양 시장을 분석하고, 제품, 유형, 응용 분야 및 최종 사용자별로 시장 규모 정보를 제공합니다.

이 시장 보고서에서 다루는 국가는 독일, 영국, 프랑스, ​​러시아, 이탈리아, 터키, 네덜란드, 스위스, 스페인, 벨기에와 기타 유럽 국가입니다.

  • 2022년에는 유럽 자동 세포 배양 시장이 줄기세포 연구, 백신 생산, 재생 의약품 생산, 약물 발견 분야에서 응용 분야가 늘어나면서 성장할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 유럽 자동 세포 배양 시장 점유율 분석

유럽 ​​자동화 세포 배양 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선입니다. 제공된 위의 데이터 포인트는 유럽 자동화 세포 배양 시장에 대한 회사의 초점과만 관련이 있습니다.

유럽 ​​자동 세포 배양 시장의 주요 기업으로는 Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, Advanced Instruments, Benchmark scientific, Inc., BioSpherix, Ltd., Biotron Healthcare, Bulldog Bio, Cell Culture Company, LLC, CellGenix GmbH, ChemoMetec, Corning Incorporated, Cytiva(Danahar Corporation의 자회사), FUJIFILM Holdings America Corporation, Hemilton Company, Hitachi, Ltd., Kawasaki Heavy Industries, ltd., HiMedia Laboratories, NanoEntek America, Inc., Nexcelom Bioscience LLC., PromoCell GmbH, RWD Life Science Co., LTD, Sartorius AG, Scientica Instrumentation, Inc., SHIBUYA CORPORATION, Sphere Fluidics Limited, Tecan Trading AG, Thrive Bioscience, Inc. 등이 있습니다.

  • 연구 방법론: 유럽 자동화 세포 배양 시장

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 유럽 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가 전화를 요청하십시오.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 REGULATORY FRAMEWORK FOR EUROPE AUTOMATED CELL CULTURES MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION

6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS

6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS

6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE

6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS

6.2 RESTRAINTS

6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS

6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES

6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT

6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

6.3 OPPORTUNITIES

6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS

6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS

6.3.3 INCREASING OUTSOURCING FACILITIES

6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE

6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES

7 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 CONSUMABLES

7.2.1 MEDIA

7.2.1.1 SERUM FREE MEDIA

7.2.1.2 CLASSICAL MEDIA & SALTS

7.2.1.3 STEM CELL CULTURE MEDIA

7.2.1.4 SPECIALTY MEDIA

7.2.2 BUFFERS AND SUPPLEMENTS

7.2.2.1 PLASMA

7.2.2.2 SERA

7.2.2.3 FETAL BOVINE SERA

7.2.2.4 ADULT BOVINE SERA

7.2.2.5 OTHERS ANIMAL SERA

7.2.3 REAGENTS

7.2.3.1 SUPPLEMENTS & GROWTH FACTORS

7.2.3.2 BUFFERS & CHEMICALS

7.2.3.3 CELL DISASSOCIATION REAGENTS

7.2.3.4 BALANCED SALT SOLUTIONS

7.2.3.5 ATTACHMENT & MATRIX FACTORS

7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS

7.2.3.7 CONTAMINATION DETECTION KITS

7.2.3.8 CRYOPROTECTIVE REAGENTS

7.2.3.9 OTHERS CELL CULTURE REAGENTS

7.2.4 ACCESSORIES

7.3 INSTRUMENTS

7.3.1 SUPPORTING EQUIPMENTS

7.3.1.1 CELL COUNTERS

7.3.1.2 IMAGE BASED CELL COUNTERS

7.3.1.3 FLOW CYTOMETERS

7.3.1.4 COULTER COUNTERS

7.3.1.5 CELL EXPANSION

7.3.1.6 LIQUID HANDLERS

7.3.1.7 OTHERS

7.3.2 BIOREACTORS

7.3.2.1 SINGLE USE BIOREACTORS

7.3.2.2 CONVENTIONAL BIOREACTORS

7.3.2.3 OTHERS

7.3.3 STORAGE EQUIPMENTS

7.3.3.1 REFRIGERATORS & FREEZERS

7.3.3.2 CRYOSTORAGE SYSTEMS

7.3.3.3 OTHERS

8 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE

8.1 OVERVIEW

8.2 INFINITE CELL LINE CULTURES

8.3 FINITE CELL LINE CULTURES

9 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 DRUG DEVELOPMENT

9.3 STEM CELL RESEARCH

9.3.1 EMBRYONIC STEM CELLS

9.3.2 TISSUE-SPECIFIC STEM CELLS

9.3.3 MESENCHYMAL STEM CELLS

9.3.4 INDUCED PLURIPOTENT STEM CELLS

9.4 REGENERATIVE MEDICINE

9.4.1 STEM CELL THERAPY

9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)

9.4.3 TISSUE ENGINEERING

9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS

9.5 CANCER RESEARCH

9.6 VACCINES

9.7 OTHERS

10 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER

10.1 OVERVIEW

10.2 BIOTECH COMPANIES

10.3 RESEARCH ORGANIZATIONS

10.4 ACADEMIC RESEARCH INSTITUTES

10.5 OTHERS

11 EUROPE AUTOMATED CELL CULTURES MARKET, BY REGION

11.1 EUROPE

11.1.1 GERMANY

11.1.2 U.K.

11.1.3 FRANCE

11.1.4 RUSSIA

11.1.5 ITALY

11.1.6 TURKEY

11.1.7 NETHERLANDS

11.1.8 SWITZERLAND

11.1.9 SPAIN

11.1.10 BELGIUM

11.1.11 REST OF EUROPE

12 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 COMPANY PROFILE

13.1 LONZA

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.1.6 SWOT ANALYSIS

13.2 MERCK KGAA

13.2.1 COMPANY SNAPSHOT

13.2.2 RECENT FINANCIALS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.2.6 SWOT ANALYSIS

13.3 THERMO FISHER SCIENTIFIC INC.

13.3.1 COMPANY SNAPSHOT

13.3.2 RECENT FINANCIALS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.3.6 SWOT ANALYSIS

13.4 BD

13.4.1 COMPANY SNAPSHOT

13.4.2 RECENT FINANCIALS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.4.6 SWOT ANALYSIS

13.5 EPPENDORF AG

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.5.6 SWOT ANALYSIS

13.6 ADVANCED INSTRUMENTS

13.6.1 COMPANY SNAPSHOT

13.6.2 PRODUCT PORTFOLIO

13.6.3 RECENT DEVELOPMENTS

13.7 BENCHMARK SCIENTIFIC INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 PRODUCT PORTFOLIO

13.7.3 RECENT DEVELOPMENTS

13.8 BIOSPHERIX LTD.

13.8.1 COMPANY SNAPSHOT

13.8.2 PRODUCT PORTFOLIO

13.8.3 RECENT DEVELOPMENTS

13.9 BIOTRON HEALTHCARE

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENTS

13.1 BULLDOG-BIO, INC.

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.11 CELL CULTURE COMPANY, LLC

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENT

13.12 CELLGENIX GMBH

13.12.1 COMPANY SNAPSHOT

13.12.2 PRODUCT PORTFOLIO

13.12.3 RECENT DEVELOPMENTS

13.13 CHEMOMETEC

13.13.1 COMPANY SNAPSHOT

13.13.2 REVENUE ANALYSIS

13.13.3 PRODUCT PORTFOLIO

13.13.4 RECENT DEVELOPMENT

13.14 CORNING INCORPORATED

13.14.1 COMPANY SNAPSHOT

13.14.2 RECENT FINANCIALS

13.14.3 PRODUCT PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)

13.15.1 COMPANY SNAPSHOT

13.15.2 REVENUE ANALYSIS

13.15.3 PRODUCT PORTFOLIO

13.15.4 RECENT DEVELOPMENTS

13.16 FUJIFILM HOLDINGS AMERICA CORPORATION

13.16.1 COMPANY SNAPSHOT

13.16.2 REVENUE ANALYSIS

13.16.3 PRODUCT PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 HAMILTON COMPANY

13.17.1 COMPANY SNAPSHOT

13.17.2 PRODUCT PORTFOLIO

13.17.3 RECENT DEVELOPMENTS

13.18 HITACHI, LTD.

13.18.1 COMPANY SNAPSHOT

13.18.2 REVENUE ANALYSIS

13.18.3 PRODUCT PORTFOLIO

13.18.4 RECENT DEVELOPMENTS

13.19 KAWASAKI HEAVY INDUSTRIES, LTD.

13.19.1 COMPANY SNAPSHOT

13.19.2 REVENUE ANALYSIS

13.19.3 PRODUCT PORTFOLIO

13.19.4 RECENT DEVELOPMENTS

13.2 HIMEDIA LABORATORIES

13.20.1 COMPANY SNAPSHOT

13.20.2 PRODUCT PORTFOLIO

13.20.3 RECENT DEVELOPMENTS

13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)

13.21.1 COMPANY SNAPSHOT

13.21.2 PRODUCT PORTFOLIO

13.21.3 RECENT DEVELOPMENTS

13.22 NEXCELOM BIOSCIENCE LLC.

13.22.1 COMPANY SNAPSHOT

13.22.2 PRODUCT PORTFOLIO

13.22.3 RECENT DEVELOPMENTS

13.23 PROMOCELL GMBH

13.23.1 COMPANY SNAPSHOT

13.23.2 PRODUCT PORTFOLIO

13.23.3 RECENT DEVELOPMENTS

13.24 RWD LIFE SCIENCE CO LTD.

13.24.1 COMPANY SNAPSHOT

13.24.2 PRODUCT PORTFOLIO

13.24.3 RECENT DEVELOPMENTS

13.25 SARTORIUS AG

13.25.1 COMPANY SNAPSHOT

13.25.2 REVENUE ANALYSIS

13.25.3 PRODUCT PORTFOLIO

13.25.4 RECENT DEVELOPMENTS

13.26 SCIENTICA INSTRUMENTATION, INC.

13.26.1 COMPANY SNAPSHOT

13.26.2 PRODUCT PORTFOLIO

13.26.3 RECENT DEVELOPMENTS

13.27 SHIBUYA CORPORATION

13.27.1 COMPANY SNAPSHOT

13.27.2 RECENT FINANCIALS

13.27.3 PRODUCT PORTFOLIO

13.27.4 RECENT DEVELOPMENTS

13.28 SPHERE FLUIDICS LIMITED

13.28.1 COMPANY SNAPSHOT

13.28.2 PRODUCT PORTFOLIO

13.28.3 RECENT DEVELOPMENTS

13.29 TECAN TRADING AG

13.29.1 COMPANY SNAPSHOT

13.29.2 RECENT FINANCIALS

13.29.3 PRODUCT PORTFOLIO

13.29.4 RECENT DEVELOPMENT

13.3 THRIVE BIOSCIENCE, INC.

13.30.1 COMPANY SNAPSHOT

13.30.2 PRODUCT PORTFOLIO

13.30.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

표 목록

TABLE 1 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 2 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 3 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 4 EUROPE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 5 EUROPE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 6 EUROPE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)

TABLE 7 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 8 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 9 EUROPE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 10 EUROPE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 11 EUROPE STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 12 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 13 EUROPE INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 14 EUROPE FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 15 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 16 EUROPE DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 17 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 18 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 19 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 20 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 21 EUROPE CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 22 EUROPE VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 23 EUROPE OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 24 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 25 EUROPE BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 26 EUROPE RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 27 EUROPE ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 28 EUROPE OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 29 EUROPE AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)

TABLE 30 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 31 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 32 EUROPE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 33 EUROPE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 34 EUROPE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 35 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 36 EUROPE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 37 EUROPE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 38 EUROPE STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 39 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 40 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 41 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 42 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 43 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 44 GERMANY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 45 GERMANY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 46 GERMANY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 47 GERMANY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 48 GERMANY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 49 GERMANY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 50 GERMANY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 51 GERMANY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 52 GERMANY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 53 GERMANY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 54 GERMANY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 55 GERMANY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 56 GERMANY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 57 GERMANY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 58 U.K. AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 59 U.K. CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 60 U.K. MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 61 U.K. BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 62 U.K. REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 63 U.K. INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 64 U.K. SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 65 U.K. BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 66 U.K. STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 67 U.K. AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 68 U.K. AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 69 U.K. STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 70 U.K. REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 71 U.K. AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 72 FRANCE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 73 FRANCE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 74 FRANCE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 75 FRANCE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 76 FRANCE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 77 FRANCE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 78 FRANCE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 79 FRANCE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 80 FRANCE STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 81 FRANCE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 82 FRANCE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 83 FRANCE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 84 FRANCE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 85 FRANCE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 86 RUSSIA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 87 RUSSIA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 88 RUSSIA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 89 RUSSIA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 90 RUSSIA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 91 RUSSIA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 92 RUSSIA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 93 RUSSIA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 94 RUSSIA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 95 RUSSIA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 96 RUSSIA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 97 RUSSIA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 98 RUSSIA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 99 RUSSIA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 100 ITALY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 101 ITALY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 102 ITALY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 103 ITALY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 104 ITALY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 105 ITALY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 106 ITALY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 107 ITALY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 108 ITALY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 109 ITALY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 110 ITALY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 111 ITALY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 112 ITALY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 113 ITALY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 114 TURKEY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 115 TURKEY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 116 TURKEY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 117 TURKEY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 118 TURKEY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 119 TURKEY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 120 TURKEY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 121 TURKEY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 122 TURKEY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 123 TURKEY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 124 TURKEY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 125 TURKEY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 126 TURKEY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 127 TURKEY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 128 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 129 NETHERLANDS CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 130 NETHERLANDS MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 131 NETHERLANDS BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 132 NETHERLANDS REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 133 NETHERLANDS INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 134 NETHERLANDS SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 135 NETHERLANDS BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 136 NETHERLANDS STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 137 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 138 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 139 NETHERLANDS STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 140 NETHERLANDS REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 141 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 142 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 143 SWITZERLAND CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 144 SWITZERLAND MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 145 SWITZERLAND BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 146 SWITZERLAND REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 147 SWITZERLAND INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 148 SWITZERLAND SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 149 SWITZERLAND BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 150 SWITZERLAND STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 151 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 152 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 153 SWITZERLAND STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 154 SWITZERLAND REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 155 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 156 SPAIN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 157 SPAIN CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 158 SPAIN MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 159 SPAIN BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 160 SPAIN REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 161 SPAIN INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 162 SPAIN SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 163 SPAIN BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 164 SPAIN STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 165 SPAIN AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 166 SPAIN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 167 SPAIN STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 168 SPAIN REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 169 SPAIN AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 170 BELGIUM AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 171 BELGIUM CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 172 BELGIUM MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 173 BELGIUM BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 174 BELGIUM REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 175 BELGIUM INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 176 BELGIUM SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 177 BELGIUM BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 178 BELGIUM STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 179 BELGIUM AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 180 BELGIUM AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 181 BELGIUM STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 182 BELGIUM REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 183 BELGIUM AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 184 REST OF EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

그림 목록

FIGURE 1 EUROPE AUTOMATED CELL CULTURES MARKET: SEGMENTATION

FIGURE 2 EUROPE AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS

FIGURE 4 EUROPE AUTOMATED CELL CULTURES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 EUROPE AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE AUTOMATED CELL CULTURES MARKET: SEGMENTATION

FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE EUROPE AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD

FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE AUTOMATED CELL CULTURES MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE AUTOMATED CELL CULTURES MARKET

FIGURE 14 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021

FIGURE 15 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)

FIGURE 16 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 17 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021

FIGURE 19 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)

FIGURE 20 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 21 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021

FIGURE 23 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)

FIGURE 24 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 25 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, 2021

FIGURE 27 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)

FIGURE 28 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 29 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 EUROPE AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)

FIGURE 31 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)

FIGURE 32 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 33 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 34 EUROPE AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)

FIGURE 35 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.